Contents of this document
- Revenue up¥2,161 million
- Higher copper prices¥1,197 million
- Foreign exchange-related losses¥159 million
- Decrease in R&D expenses¥21 million
- Lower depreciation expense¥2 million
- New mass-production products for automotive cables
- Expansion of production of new mass-production products for semiconductor manufacturing equipment cables
- New medical components
- EPS133 yen
- BPS2,878 yen
- Foreign-currency revenue ratio within the segment (wire and processed products)63 %
- Foreign-currency revenue ratio within the segment (electronic and medical components)21 %
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | ¥25,539 million (YoY +41.2%) |
| Operating profit | ¥2,952 million (YoY +38.9%) |
| Ordinary income | ¥3,006 million (YoY +48.0%) |
| Net income | ¥2,082 million (YoY +15.4%) |
| Operating profit margin | 11.6% |
| Results for the three months of the current quarter | Wires and Processed Products Sales First quarter ¥11,240 million / Second quarter ¥11,882 million / Electronic and Medical Components Sales First quarter ¥1,196 million / Second quarter ¥1,203 million |
| Full-year earnings forecast | Net Sales ¥48,000 million / Operating profit ¥5,500 million / Ordinary income ¥5,700 million / Net income attributable to owners of the parent ¥4,100 million / EPS 263 yen / BPS 2,941 yen / ROE 9.3% |
| Segment results | Electric Wires and Processed Products Net Sales ¥23,112 million / Year on year against the same period last year +50.4% / Electronic and medical components Net Sales ¥2,399 million / Year on year against the same period last year -11.4% / Wires and Processed Products Profit ¥3,008 million / Electronic and Medical Components Profit ¥464 million |
| Breakdown of Factors Affecting the Change | Factors Revenue up / Amount ¥2,161 million, Factors Higher copper prices / Amount ¥1,197 million, Factors Foreign exchange-related losses / Amount ¥159 million, Factors Decrease in R&D expenses / Amount ¥21 million, Factors Lower depreciation expense / Amount ¥2 million |
| Key KPIs | Indicator name EPS / Value 133 yen / Year on year against the same period last year Not disclosed, Indicator name BPS / Value 2,878 yen / Year on year against the same period last year Not disclosed, Indicator name Foreign-currency revenue ratio within the segment (wire and processed products) / Value 63 % / Year on year against the same period last year Not disclosed, Indicator name Foreign-currency revenue ratio within the segment (electronic and medical components) / Value 21 % / Year on year against the same period last year Not disclosed |
| Assumptions Underlying the Business Outlook | Exchange rate ¥160 per US dollar (full year) / Copper basis US$13,000/t (full year) |
| Financial targets | ROE 9.3% |
| Annual Dividend | ¥57 per share |
| Payout ratio | 21.6% |
| Capital expenditures | ¥1,550 millions (plan for the fiscal year ending March 2027) |
| New initiatives | New mass-production products for automotive cables, Expansion of production of new mass-production products for semiconductor manufacturing equipment cables, New medical components |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the wire and processed products segment, new mass-production products, North American energy-related demand, and products for semiconductor manufacturing equipment, factory automation and robotics performed well. The revisions to the full-year forecasts reflect, among other factors, a change in the assumed exchange rate from ¥155 per US dollar to ¥160 per US dollar.